Ignite Creation Date:
2024-05-06 @ 5:49 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05441956
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-10
First Post:
2022-06-23
Brief Title:
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer NSCLC
Sponsor:
Shenzhen TargetRx Inc
Organization:
Shenzhen TargetRx Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-small Cell Lung Cancer |
Keywords: